UPDATED: FDA rejects Google's push to add virtual exam for Parkinson’s disease to its smartwatch
The FDA recently shot down an attempt by Google’s Verily to qualify the addition of a virtual motor exam for Parkinson’s disease to its smartwatch.
In its rejection letter, the agency said the motor exam and Verily’s algorithm, which sought to assess the motor symptom severity in adults who have been diagnosed with the debilitating disease, are “limited in their capacity to evaluate meaningful aspects of concepts of interest that are relevant to the patients’ ability to function in day-to-day life.”
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 120,000+ biopharma pros reading Endpoints daily — and it's free.